AnGes Inc (AMGXF)
0.3353
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
AnGes Net Income (Quarterly): -17.88M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -17.88M |
| September 30, 2023 | 0.2202M |
| June 30, 2023 | -13.98M |
| March 31, 2023 | -22.04M |
| December 31, 2022 | -32.06M |
| September 30, 2022 | -20.04M |
| June 30, 2022 | -34.63M |
| March 31, 2022 | -25.29M |
| December 31, 2021 | -15.15M |
| September 30, 2021 | -40.91M |
| June 30, 2021 | -37.78M |
| March 31, 2021 | -31.29M |
| December 31, 2020 | -9.908M |
| September 30, 2020 | -12.05M |
| June 30, 2020 | -9.070M |
| March 31, 2020 | -8.448M |
| December 31, 2019 | -9.014M |
| September 30, 2019 | -7.430M |
| June 30, 2019 | -7.187M |
| March 31, 2019 | -10.75M |
| December 31, 2018 | -7.042M |
| September 30, 2018 | -9.469M |
| June 30, 2018 | -5.594M |
| March 31, 2018 | -4.956M |
| December 31, 2017 | -3.589M |
| Date | Value |
|---|---|
| September 30, 2017 | -9.553M |
| June 30, 2017 | -7.092M |
| March 31, 2017 | -13.30M |
| December 31, 2016 | -8.731M |
| September 30, 2016 | -9.756M |
| June 30, 2016 | -14.77M |
| March 31, 2016 | -10.68M |
| December 31, 2015 | -9.348M |
| September 30, 2015 | -7.920M |
| June 30, 2015 | -9.530M |
| March 31, 2015 | -7.419M |
| December 31, 2014 | -2.436M |
| September 30, 2014 | -10.79M |
| June 30, 2014 | -5.187M |
| March 31, 2014 | -4.268M |
| December 31, 2013 | -4.360M |
| September 30, 2013 | -3.230M |
| June 30, 2013 | -2.894M |
| March 31, 2013 | -3.981M |
| December 31, 2012 | -5.683M |
| September 30, 2012 | -4.488M |
| June 30, 2012 | -5.508M |
| March 31, 2012 | -5.711M |
| December 31, 2011 | -7.975M |
| September 30, 2011 | -5.023M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-40.91M
Minimum
Sep 2021
0.2202M
Maximum
Sep 2023
-18.63M
Average
-15.15M
Median
Dec 2021
Net Income (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 716.00M |
| Nxera Pharma Co Ltd | -1.409M |
| PeptiDream Inc | -3.424M |
| Stemcell Holdings Inc | 1.037M |
| Healios KK | -11.72M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.3408M |
| Total Expenses (Quarterly) | 19.03M |
| EPS Diluted (Quarterly) | -0.0921 |
| Enterprise Value | 37.97M |
| Gross Profit Margin (Quarterly) | 14.39% |
| Profit Margin (Quarterly) | -5.24K% |
| Earnings Yield | -85.33% |
| Normalized Earnings Yield | -67.62 |